dihexa cancer risk c-met hgf HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeted Inhibition of Hepatocyte Growth – Role of cMET in the
Role of cMET in the Development and Progression of Colorectal Cancer Targeting c MET in gastrointestinal tumours: rationale, opportunities and challenges Nature Reviews Clinical Oncology Targeting of c MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma: Cell Reports Medicine c Met Signaling as a Therapeutic Target in Head : The Cancer Journal
Pay in 4 interest-free payments of $5.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18


